You just read:

Cantex Pharmaceuticals, Inc. Announces FDA Orphan Drug Designation Has Been Granted to CX-01 for Treatment of Acute Myeloid Leukemia

News provided by

Cantex Pharmaceuticals, Inc.

Jan 03, 2018, 10:03 EST